Miami HIV Clinic Administrator and Two Miami Residents Sentenced for Their Roles in a $14 Million Medicare Fr...(and investigated by the Department of He...),Health
Navigation Links
Miami HIV Clinic Administrator and Two Miami Residents Sentenced for Their Roles in a $14 Million Medicare Fraud Scheme
Date:11/18/2008
and investigated by the Department of Health and Human Services, Office of the Inspector General and the FBI. The case was brought as part of the Medicare Fraud Strike Force, supervised by Deputy Chief Kirk Ogrosky of the Criminal Division's Fraud Section and U.S. Attorney Acosta of the Southern District of Florida. Federal prosecutors have indicted 82 cases with 142 defendants in South Florida since investigations opened during the period of strike force operations between March and October 2007. Collectively, these defendants fraudulently billed the Medicare program for more than $492 million.
'/>"/>
| SOURCE U.S. Department of Justice Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Miami Clinic Owner Sentenced to 30 Months in Prison for $10.9 Million Medicare Fraud
2. Miami Physician Sentenced to 84 Months in Prison for $26.2 Million Medicare Fraud
3. Southern AIDS Living Quilt Project Coming to Miami
4. Aflac Celebrates With Petersons Harley Davidson of Miami as 100,000th Online Billing Customer
5. Miami HIV Clinic Administrator Pleads Guilty for Role in a $14 Million Medicare Fraud Scheme
6. National Ovarian Cancer Coalition and CSI: Miami Star Eva La Rue Launch Evas Divas in Hollywood to Educate Women Nationwide About Ovarian Cancer
7. HealthCare.com Adds The Miami Herald to its Care Provider Search™ Network
8. MORSE LLC - CyberKnife Centers of Miami and Palm Beach Mark Expansion Into Southwest Florida
9. Three Miami Area Brothers and Physicians Assistant Charged In $110 Million Health Care Fraud Scheme
10. Miami Institute Launches New Weight Loss Program
11. Three Miami Area Doctors and Six Others Charged in $56 Million Health Care Fraud Schemes
Post Your Comments:
(Date:11/22/2009)...ria are abundant, diverse and constant, but inflam... of California, San Diego School of Medicine now s...urface trigger a pathway that prevents excessive i...ually good for us," said Richard L. Gallo, MD, PhD...CSD,s Division of Dermatology and the Dermatology ...
(Date:11/22/2009)...thSmart, an innovative healthcare benefit solution...y completed a recapitalization with Silver Point C.... Silver Point Capital, L.P. is a private investm...capitalization allows the Company to continue its ... (PRWEB) November 22, 2009 ...
(Date:11/21/2009)...1 Tonight, in a partisa...r Reid,s version of the government takeover of hea...cluded in this bill; like the public option, emplo...ding for elective abortion, which is the most oner...ll provides subsidies for private plans that cover...
(Date:11/21/2009)...21 A regional initiativ...s (river blindness) in the Americas has substantia...t years, as evidenced by a 31% decrease in the num...ion in six endemic countries. Results were report...n Society of Tropical Medicine and Hygiene (ASTMH)...
(Date:11/21/2009)...vative medical apparel company launches men,s lab ... San Clemente, Calif. (PRWEB) November 21,...cal apparel, today announced the launch of its men... a leading international trade fair for the medica...naugurates its men,s collection with three varying...
Breaking Medicine News(10 mins):Health News:Surface bacteria maintain skin's healthy balance 2Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3[0] Surface bacteria maintain skin's healthy balance[1] HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman [0] FRC: Senate Votes to Proceed with Abortion Funding Debacle[0] River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries[0] Medelita Introduces Men's Lab Coat Collection
...sLuce Vice President Johna Burke will describe com...gap in remarks to be delivered on Tuesday, Jan. 6,...by the South Carolina Chapter of the International...ello at 803-255-2635 or stefanie.caraviello (at) s...
...chnology, Inc. (eRT), (Nasdaq: ERES ), a leading...ogy, ePRO and other services to the pharmaceutical...ries, announced today that Dr. Michael J. McKelvey...Annual J.P. Morgan Healthcare Conference at 4:00 p...
...x, Inc. (Nasdaq: MSON ), a developer of minimall...hich in Europe is used for the ablation of tumors ...as entered into a definitive, 3-year distribution ...nnounced on November 7, 2008. Under the terms of t...
...8Scientists at Burnham Institute for Medical Resea...s for the protein kinase complex Cdc7/Dbf4 or Cdc7...A replication and reinitiating replication followi...herapies. The research was published in the Decemb...
...adon Action Month, , , HARRISBURG, Pa., Jan. 5 U...s seeping into homes could help prevent lung cance...f Environmental Protection Secretary John Hanger s...re stores or by contacting a Pennsylvania certifie...
...in have been used for centuries to treat patients ... are still in use today. In the Dec. 16 issue of t...s , researchers at the Johns Hopkins University Sc...isting drugs that might slow or stop cancer progre...
Other Medicine News:Health News:South Carolina IABC Event to Hear from BurrellesLuce Exec on Best Ways to Reach Multi-Generation Audience 2Health News:South Carolina IABC Event to Hear from BurrellesLuce Exec on Best Ways to Reach Multi-Generation Audience 3Health News:eResearchTechnology, Inc. to Present at the J.P. Morgan Healthcare Conference on January 13, 2009 2Health News:Misonix Announces New HIFU Distribution Agreement for Italy 2Health News:Misonix Announces New HIFU Distribution Agreement for Italy 3Health News:Burnham researchers illuminate mechanisms that regulate DNA damage control and replication 2Health News:Inexpensive Test Can Help Prevent Lung Cancer Caused By Radon 2Health News:New hope for cancer comes straight from the heart 2South Carolina IABC Event to Hear from BurrellesLuce Exec on Best Ways to Reach Multi-Generation AudienceeResearchTechnology, Inc. to Present at the J.P. Morgan Healthcare Conference on January 13, 2009Misonix Announces New HIFU Distribution Agreement for ItalyBurnham researchers illuminate mechanisms that regulate DNA damage control and replicationInexpensive Test Can Help Prevent Lung Cancer Caused By RadonNew hope for cancer comes straight from the heart
(Date:11/19/2009)...-- In response to an ever-increasing number of web...peration Pangea II, involving 24 countries, was co...ation,s International Medical Products Anti-Counte...rs of buying medicines online. ,, The week long... and the seizure of thousands of potentially harmf...
(Date:11/19/2009)...ewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc....te presentation will be webcast live during the 21...Wednesday, December 2, 2009 at 9:00 a.m. Eastern T...w York Palace Hotel in New York and will be presen... ,, To access the live presentation via the Web...
(Date:11/19/2009)...wire/ -- Ligon Discovery, Inc., which uses proprie...drugs against high-value targets, today announced ...cTANK Ventures. The company will use the capital t...l screen over 100 high-value disease protein targe... Partner Christian Bailey joins the board. ,, P...
Breaking Medicine Technology:International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 1Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 2Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 3Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 4Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 5Hip Arthroscopy Procedures to Soar Through 2013 51045 1Hip Arthroscopy Procedures to Soar Through 2013 51045 2DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 1DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 2DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 3DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 4DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 5... Phase 1/2 Trial of TRU-016, Trubion,s Proprietary...I-087 for RA Expands Trubion,s Family of Customize...t Candidates, SEATTLE, March 27 Trubion Pharmace... it has initiated a Phase 1/2,clinical trial of TR...r,ImmunoPharmaceutical (SMIP(TM)) drug candidate, ...
...ng Therapeutic Value of Cord Blood Stem Cells, OL...bilical cord blood are showing early potential in ... from a new preclinical study,published in the Mar...conducted by researchers from the University of So...ound that targeted immune suppression using stem,c...
Other Medicine Technology:Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 2Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 3Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 4Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 5Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 2Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 3Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 4Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 5New Image Pre-sized Flextend Skin Barrier, Floating Flange, with Tape
New Image Pre-sized Flextend Skin Barrier, Floating Flange
New Image Pre-sized Convex FlexWear Skin Barrier, Floating Flange
New Image Pre-Sized Convex Flextend Skin Barrier, Floating Flange
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |